(Press-News.org)
Over four hundred people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic Leukaemia (B-ALL) next year in Spain, according to the latest projections from the Spanish network of cancer registries (REDECAN). Survival rates for this rapid-growing and aggressive type of blood cancer are high in youth, but fall rapidly with age, especially after 40, stressing the need for new therapeutic alternatives.
B-ALL arises when B-lymphocytes - the antibody producing cells of the immune system - fail to properly mature in the bone marrow, leading to the accumulation of immature progenitors and affecting the whole production of blood cells. This causes severe symptoms, like anaemia, generalised weakness and immune failure. While current therapeutic options include chemotherapy and immunotherapy, this study opens new avenues for novel approaches aiming at restoring normal B cell maturation.
The prestigious journal Nature Immunology publishes the latest work of the Chromatin Biology lab, led by Dr. Alejandro Vaquero at the Josep Carreras Institute, in which researchers describe a molecular mechanism controlling the transcription factor PAX5, the key regulator of B-cell maturation and a well-documented target for B-ALL. To this end, the team, spearheaded by Andrés Gámez and co-supervised by Dr. Berta Vázquez, teamed-up with other researchers at the Josep Carreras Institute, such as Dr. Manel Esteller and Dr. Jose Luis Sardina, as well as from other institutions in Spain and abroad.
PAX5 regulates B-cell identity by controlling the activation of its genetic program, guiding B-cell progenitors through the maturation process. According to the research, this is an exceptionally subtle process in which PAX5 is sequentially stabilised and de-stabilised through a chemical modification known as acetylation. Two proteins are in charge of these chemical modifications: the deacetylase SIRT7 on one side, removing the modification, and the acetyltransferase PCAF on the other, adding it to PAX5.
SIRT7, from the sirtuin family, has been extensively studied in the last years by Dr. Vaquero’s group in collaboration with well-recognized experts from around the world (Sweden, USA, and Germany) and the results show that it is a very important protein during B-cell development, among other important cellular processes. In the current research, SIRT7 deacetylase activity enhances PAX5 stability within the cell, allowing its activity for longer times. In fact, the expression profile of SIRT7 increases during B-cell maturation in vivo, and closely correlates with PAX5 expression levels. Conversely, absence of SIRT7 in mice blocks B-cell differentiation in the bone marrow, producing immunodeficiency.
Mutations inactivating one copy of the PAX5 gene -we humans have two copies of each gene- are found in 30% of B-ALL cases. It turns out our cells need the two copies working to produce enough PAX5, so these monoallelic mutations count as an important driver of leukemogenesis. Furthermore, increasing PAX5 protein levels in B-ALL cells is known to induce leukemic cell death. Thanks to the new understanding of the PAX5 delicate balance, and to the ability of SIRT7 to control it, the research team suggests a possible new therapeutic approach aiming at reinforcing SIRT7 activity in B-ALL patients to keep PAX5 levels higher within leukemic cells.
Fundamental research on clinical challenges has the potential to broaden our view of diseases like B-ALL and other related illnesses, like B-cell chronic leukaemia and T-cell leukaemia, and deeper understandings open the door to innovative approaches, that can make a difference for blood cancer patients in the future.
This research has been funded partly by grants from the Spanish Association Against Cancer (AECC), the Spanish, Catalan and Swedish governments and the European Union. No generative AI tools have been used in the production of this news piece.
Reference Article:
Gamez-Garcia A, Espinosa-Alcantud M, Bueno-Costa A, Alari-Pahissa E, Marazuela-Duque A, Thackray JK, Ray C, Berenguer C, Kumari P, Bech JJ, Braun T, Ianni A, Tischfield J, Serrano L, Esteller M, Sardina JL, De La Torre C, Sigvardsson M, Vazquez BN, Vaquero A. A SIRT7-dependent acetylation switch regulates early B-cell differentiation and lineage commitment through PAX5. Nat. Immunol. 2024. Oct 18. doi:10.1038/s41590-024-01995-7
END
A new study by researchers at Zhejiang University has highlighted the disproportionate health challenges faced by sexual and gender-diverse (SGD) individuals during the COVID-19 pandemic. By analyzing over 471 million tweets using advanced natural language processing (NLP) techniques, the study reveals that SGD individuals were more likely to discuss concerns related to social connections, mask-wearing, and experienced higher rates of COVID-19 symptoms and mental health issues than non-SGD individuals. The study has been published in the journal Health Data ...
A new study1 has unveiled the Hispanic Thrifty Food Plan (H-TFP), a culturally adapted and affordable diet specifically designed to align with the eating habits of U.S. Hispanic households. The research, led by Adam Drewnowski, PhD, from the University of Washington, used advanced dietary modeling to create a version of the USDA’s Thrifty Food Plan (TFP) that respects the distinctive food patterns of Hispanic communities.
The USDA's Thrifty Food Plan is the foundation for setting benefits under the Supplemental Nutrition Assistance Program (SNAP), but it has not traditionally accounted for the ...
An innovative study, to be published in Nature Communications on October 21, 2024, reveals the mechanism behind two seemingly contradictory effects of fear memories: the inability to forget yet the difficulty to recall. Led by researchers from Sony Computer Science Laboratories, Inc., ATR Computational Neuroscience Laboratories, and the University of Tokyo, the study shows how fear experiences are initially remembered as broad, associative memories, but over time become integrated into episodic memories with a more specific timeline.
The researchers conducted experiments using functional ...
Guideline Highlights:
Each year in the U.S., over half a million people have a first stroke; however, up to 80% of strokes may be preventable.
The new primary prevention of stroke guideline from the American Stroke Association urges health care professionals to screen people for stroke risk factors, including high blood pressure, elevated cholesterol, high blood sugar and obesity.
Increasing public awareness and knowledge about healthy lifestyle changes, such as smoking cessation, increased physical activity, improved dietary habits and better sleep, may also help people reduce their stroke risk.
The new guideline highlights the American Heart ...
It is one of the most fundamental questions in science: how can lifeless molecules come together to form a living cell? Bert Poolman, Professor of Biochemistry at the University of Groningen, has been working on this problem for over twenty years. He aims to understand life by trying to reconstruct it; he is building simplified artificial versions of biological systems that can be used as components for a synthetic cell. Poolman recently published two papers in Nature Nanotechnology and Nature Communications. In the first paper, he describes a system for energy conversion ...
In one of the largest-ever studies of DNA and brain volume, researchers have identified 254 genetic variants that shape key structures in the “deep brain,” including those that control memory, motor skills, addictive behaviors and more. The findings were just published in the journal Nature Genetics.
The study is powered by the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) consortium, an international effort based at the Keck School of Medicine of USC, which unites more than 1,000 research labs across 45 countries to hunt for genetic variations that affect the brain’s structure and function.
“A lot of brain diseases are known to be partially ...
Food production is one of the pillars of human civilization and underlies many of the changes caused by humans on planet’s landscapes. Producing food and getting it to people’s plates entails a significant expenditure of energy and resources. Unfortunately, approximately one third of all food produced globally is not consumed and discarded. Hence, to build sustainable societies, it is essential to minimize food waste.
In Japan, based on estimates reported by governmental institutions, an astonishing 2.47 megatons of food waste was generated in ...
Many women who receive chemotherapy experience a decreased ability to remember, concentrate, and/or think—commonly referred to as “chemo-brain” or “brain fog”—both short- and long-term. In a recent clinical trial of women initiating chemotherapy for breast cancer, those who simultaneously started an aerobic exercise program self-reported greater improvements in cognitive function and quality of life compared with those receiving standard care. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
The study, called the Aerobic exercise and ...
ANN ARBOR, Mich. – Protein bars, shakes and powders are increasingly popular among adults – but many teens may be jumping on the bandwagon too.
Two in five parents say their teen consumed protein supplements in the past year, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health. The trend was more common among teen boys who were also more likely to take protein supplements every day or most days, parents reported.
“Protein is part of a healthy diet but it can be hard for parents to tell if ...
SAN DIEGO, California, 21 October 2024. In an illuminating Genomic Press Interview published today, Dr. Stephanie Knatz Peck, Associate Clinical Professor of Psychiatry at the University of California, San Diego (UCSD), unveils her groundbreaking work in eating disorder treatment and psychedelic research. The interview, featured in the journal Psychedelics, offers an intimate look at Dr. Knatz Peck's journey from personal struggle with an eating disorder to becoming a leading innovator in the field.
Dr. Knatz Peck's research ...
